ArticleDrug delivery and translational research2025

Intranasal delivery of engineered anti-SARS-CoV-2 extracellular vesicles therapeutically represses lung infection and inflammation.

Adi Idris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.